Healthlead PCL (BKK:HL)

Thailand · Delayed Price · Currency is THB

4.480

-0.020 (-0.44%)

Sep 11, 2026, 4:36 PM ICT

Market Cap	1.14B -44.0%
Revenue (ttm)	2.26B +3.6%
Net Income	59.45M -30.2%
EPS	0.23 -27.4%
Shares Out	253.88M
PE Ratio	19.72
Forward PE	n/a
Dividend	0.22 (4.76%)
Ex-Dividend Date	Mar 11, 2026

Volume	92,517
Open	4.500
Previous Close	4.500
Day's Range	4.480 - 4.500
52-Week Range	4.460 - 8.450
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 17, 2026

About Healthlead PCL

Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi,... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 2018

Employees 3

Stock Exchange Stock Exchange of Thailand

Ticker Symbol HL

Full Company Profile

Financial Performance

In 2025, Healthlead PCL's revenue was 2.27 billion, an increase of 12.85% compared to the previous year's 2.01 billion. Earnings were 77.86 million, a decrease of -0.52%.

Financial Statements